Verified Nov 2026
Other
·

Salisbury, England
·
Since 2015
Porton Biopharma Limited is a UK-based biopharmaceutical manufacturer founded in 2015, headquartered in Salisbury, England, with 100-200 employees and estimated revenue of $10-50 million. The company specializes in developing and manufacturing niche therapeutics and vaccines for cancer, infectious diseases, and critical health conditions, serving healthcare providers, military personnel, and government partners globally. The company is the sole manufacturer of Erwinase, an essential treatment for acute lymphoblastic leukaemia, and produces the UK's licensed anthrax vaccine.
Porton Biopharma Ltd at a glance
Revenue
$10-50M
Est. band
Employees
100-200
Founded
2015
Headquarters
Salisbury, England
Industries
Automotive
Electric Vehicles
Medical
Military & Defense
Overview
Porton Biopharma Limited is a UK-based biopharmaceutical manufacturer founded in 2015, headquartered in Salisbury, England, with 100-200 employees and estimated revenue of $10-50 million. The company specializes in developing and manufacturing niche therapeutics and vaccines for cancer, infectious diseases, and critical health conditions, serving healthcare providers, military personnel, and government partners globally. The company is the sole manufacturer of Erwinase, an essential treatment for acute lymphoblastic leukaemia, and produces the UK's licensed anthrax vaccine.
At a glance
Attribute | Detail |
|---|---|
Founded | 2015 |
Headquarters | Salisbury, England |
Employees | 100-200 |
Revenue | $10-50M (estimated) |
What Porton Biopharma Ltd makes
Porton Biopharma develops and manufactures therapeutic proteins, enzymes, and vaccines alongside contract manufacturing services that include process development, analytical development, and fermentation expertise for biological pharmaceuticals.
Latest developments
2026-08-26 — Porton Biopharma Cuts Infrastructure Costs by Over £200,000 with Scale Computing and Nexstor | Nexstor (nexstor.com)
2026-08-05 — When Porton Biopharma Ltd needed to scale up manufacture of a life-saving cancer treatment, T-SQUARED was appointed to deliver a fully validated biopharmaceutical filling suite. | T-SQUARED (linkedin.com)
2026-05-18 — Novartis terminates plant contract with Chinese CDMO Porton, threatens $64M in legal claims | Fierce Pharma (fiercepharma.com)
2025-03-06 — EXCL: DHSC-owned drug development company to cease manufacturing (civilserviceworld.com)
Company details
The company was spun out from Public Health England in 2015 and operates as a privately held manufacturer serving critical global health markets. Porton Biopharma Ltd was founded in 2015, has an estimated 100-200 employees, and is headquartered in Salisbury, England.
Frequently asked questions
What does Porton Biopharma Ltd do?
Porton Biopharma Limited is a UK-based biopharmaceutical manufacturer founded in 2015, headquartered in Salisbury, England, with 100-200 employees and estimated revenue of $10-50 million. The company specializes in developing and manufacturing niche therapeutics and vaccines for cancer, infectious diseases, and critical health conditions, serving healthcare providers, military personnel, and government partners globally. The company is the sole manufacturer of Erwinase, an essential treatment for acute lymphoblastic leukaemia, and produces the UK's licensed anthrax vaccine.
Where is Porton Biopharma Ltd headquartered?
Porton Biopharma Ltd is headquartered in Salisbury, England (Manor Farm Road, Salisbury, England, SP4 0).
When was Porton Biopharma Ltd founded?
Porton Biopharma Ltd was founded in 2015.
How big is Porton Biopharma Ltd?
Porton Biopharma Ltd has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
